For example, the triple negative molecular subtype (estrogen/progesterone/HER2 negative) accounts for approximately 40% of breast cancer LMD cases, however only is diagnosed in 10% of all breast cancer patients, indicating a clear overrepresentation of this subtype among LMD patients. The gene discussed is ERBB2; the disease is breast cancer.